ReviewHeart (British Cardiac Society)2020
Comprehensive review of evaluation and management of cardiac paragangliomas.
Review in Heart (British Cardiac Society), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 38 citations in OpenAlex.
- Incidental finding of a cardiac paraganglioma following ischemic stroke: A case report.Radiology case reports · 2026Article
- Transradial Embolization Prior to Surgical Resection of a Cardiac Paraganglioma Presenting as an Acute Coronary Syndrome With Normal Coronaries.The American journal of case reports · 2026Article
- Cardiac Paraganglioma.JACC. Case reports · 2026Article
- Intracardiac paraganglioma in the left atrium in the context of a hereditary syndrome due to SDHD mutation: a case report.European heart journal. Case reports · 2026Article
- Article
- Cardiac Paraganglioma Discovered Incidentally.JACC. Case reports · 2025Article
- Right Ventricular Paraganglioma Mimicking Coronary Artery Aneurysm: A Diagnostic Conundrum.JACC. Case reports · 2025Article
- Intramyocardial Hemangioma Mimicking Paraganglioma in Cardiac MRI and DOTANOC PET.The Indian journal of radiology & imaging · 2025Article
- Clinical, genetic, radiological characteristics and management of mediastinal paragangliomas: a literature review and case series.Endocrine-related cancer · 2025Review
- Perioperative Blood Pressure Management Recommendations in Pediatric Pheochromocytoma: A 10-Year Narrative Review.Kidney & blood pressure research · 2025Review
- Cardiac paraganglioma: implications and impacts of a rare disease-a case reportEuropean heart journal. Case reports · 2024Article
- Exertional Angina in a Young Woman Caused by Large Cardiac Paraganglioma.JACC. Case reports · 2024Article
- A Tumor-Feeding Artery Towards a Cardiac Glomus Tumor.Journal of the Society for Cardiovascular Angiography & Interventions · 2024Article
- Article
- Diagnosis, Genetics, and Management of 24 Patients With Cardiac Paragangliomas: Experience From a Single Center.Journal of the Endocrine Society · 2023Article
- Role of integrated imaging in the diagnosis of an atypical and unresectable cardiac paraganglioma: a case report.European heart journal. Case reports · 2023Article
- Cardiac paraganglioma in a pediatric patient.JTCVS techniques · 2023Article
- Multimodality imaging of a cardiac paraganglioma: A case report.Frontiers in cardiovascular medicine · 2023Article
- A young patient with heart failure was diagnosed with extra-adrenal paraganglioma: a case report.BMC cardiovascular disorders · 2022Article
- Multimodality Imaging of Benign Primary Cardiac Tumor.Diagnostics (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 2 countries.
Funding
Abstract
Cardiac paraganglioma (PGL) is a rare neuroendocrine tumour causing significant morbidity primarily due to norepinephrine secretion potentially causing severe hypertension, palpitations, lethal tachyarrhythmias, stroke and syncope. Cardiologists are faced with two clinical scenarios. The first is the elevated norepinephrine, whose actions must be properly counteracted by adrenoceptor blockade to avoid catastrophic consequences. The second is to evaluate the precise location of a cardiac PGL and its spread since compression of cardiovascular structures may result in ischaemia, angina, non-noradrenergic-induced arrhythmia, cardiac dysfunction or failure. Thus, appropriate assessment of elevated norepinephrine by its metabolite normetanephrine is a gold biochemical standard at present. Furthermore, dedicated cardiac CT, MRI and transthoracic echocardiogram are necessary for the precise anatomic information of cardiac PGL. Moreover, a cardiologist needs to be aware of advanced functional imaging using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.